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ABSTRACT 
The potential protective and therapeu- 
tic effects of bST during coliform masti- 
tis in periparturient cows were evaluated. 
In a first study, 19 cows, classified as 
moderate or severe responders based on 
the respiratory burst activity of blood 
neutrophils, were treated with recom- 
binant bST or vehicle 48 h after in- 
tramammary inoculation of Escherichia 
coZi. Clinical status and changes in milk 
production and composition were com- 
pared in the four groups. In a second 
study, 8 cows received bST or vehicle 7 
d before bacterial challenge. 
During mastitis, losses in milk 
production and compositional changes 
were most pronounced in infected glands 
and in severe responders. Milk produc- 
tion of bST cows recovered better than 
that of placebo cows. Recovery of milk 
components was accelerated in severe 
responders treated with bST, but not in 
moderate responders. Pretreatment of se- 
vere responders with bST enhanced milk 
production before infection, protected the 
mammary glands from excessive loss of 
milk during the subsequently induced 
coliform mastitis, and accelerated nor- 
malization of milk composition. 
In conclusion, the beneficial effects of 
bST upon normalization of milk produc- 
tion and composition in periparturient 
cows suffering from coliform mastitis 
seem to be restricted to the severe 
responders. In severe responders that had 
been treated with bST, changes observed 
during mastitis resembled those in 
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moderate responders treated with the 
placebo. 
(Key words: somatotropin, milk, masti- 
tis, periparturient cows) 
Abbreviation key: IMM = intramammary, 
MP = milk production. 
INTRODUCTION 
The great variability in illness and the wide 
range of pathological responses observed dur- 
ing experimentally induced Escherichia coli 
mastitis in periparturient cows (28, 29, 31) led 
us to distinguish between moderate and severe 
responders. As described earlier (29), classifi- 
cation was based upon the capacity of blood 
neutrophils of cows to generate reactive oxy- 
gen species (13) and upon differences in blood 
and milk components prior to infection. Both 
groups differed in the course and the intensity 
of clinical responses and in the changes in 
milk production (MP) and composition after 
induction of E. coli mastitis. Effects were most 
pronounced in infected glands and in severe 
responders for which recovery was slow and 
incomplete (29). 
Administration of pituitary or recombinant 
bST to healthy dairy cows increases MP; in- 
creases of 15 to 40% were reported during 
short-term or long-term treatment studies in 
early, mid, or late lactation [review, (20)]. The 
magnitude of the MP responses to bST largely 
varies with the lactation period. In early lacta- 
tion, these responses may be absent (2, 19) or 
small (8, 22). However, recent reports indicate 
that exogenous bST also is effective at 
stimulating MP even when treatment began 
within the first 3 wk after parturition (24, 26). 
In healthy cows, the action of bST seems to 
consist in repartitioning of nutrients to the 
mammary gland in order to support the re- 
quirements of milk synthesis (1). In goats, 
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pretreatment with recombinant bST increased 
MP above that for pretreatment controls and 
stimulated the recovery of MP suppressed dur- 
ing endotoxin mastitis (4). Increasingly, indica- 
tions are obtained that bST has a role in im- 
munoregulation. Somatotropin has been 
reported to be synthesized and released by 
lymphocytes (33). Exogenous bST can increase 
the proliferative responsiveness of peripheral 
blood lymphocytes stimulated by mitogen in 
culture (3), augments granulopoiesis in human 
bone marrow, and is potent in priming macro- 
phages for the production of 0 2 .  (15). Recently 
evidence was also obtained that indicates that 
bST influences the maturation and function of 
the neutrophils in the cow. Pretreatment of 
cows with bST shortly after calving increased 
total leukocyte number, increased the number 
of circulating immature band cells, and en- 
hanced the burst capacity of the neutrophils 
induced by phorbol myristate acetate [(16); C. 
Burvenich et al., 1993, unpublished data]. 
However, Elvinger et al. (10) did not observe 
any substantial effect of bST on bovine poly- 
morphonuclear leukocytes in vivo or in vitro. 
Nevertheless, all these observations suggest 
that, by stimulating the cow's defense mechan- 
isms, bST may help to protect the mammary 
gland against invading bacteria. It can be 
hypothesized that bST plays an important role 
in the outcome of mastitis and the inflamma- 
tory process of the mammary gland. This 
hypothesis is supported by the observation that 
somatotropin is released after i.v. injection of 
endotoxin in goats (5, 30) and during E. coli 
mastitis in cows (31). 
In order to obtain more information about a 
possible protective and therapeutic role for 
bST, the present study was designed to inves- 
tigate 1) whether short-term treatment with 
recombinant bST stimulates the recovery of 
MP and composition in cows suffering from 
coliform mastitis; 2) whether these effects dif- 
fer in moderate and severe responders; 3) 
whether pretreatment of cows with bST pro- 
tects the mammary gland against the negative 
aspects of E. coli mastitis; and 4) whether an 
eventually beneficial effect is comparable with 
that observed in healthy cows under physiolog- 
ical circumstances, or that, on the contrary, 
specific mechanisms concerning neutrophil 
function may be involved. Therefore, experi- 
ments were performed on second lactation 
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cows shortly after calving. Changes in MP and 
composition after induction of mastitis were 
compared in moderate and severe responders 
treated with vehicle or bST. 
MATERIALS AND METHODS 
cows 
Twenty-seven cows of the East Flemish 
Red Pied breed and mean (f SEM) body 
weight of 554.4 It 21.5 kg were used. Cows 
were in their second lactation, healthy, and free 
of udder infection. At the commencement of 
the study, cows were 23.6 f 2.7 d postpartum. 
Before the cows were purchased, the udder 
was examined clinically, and quarter foremilk 
samples were obtained for bacteriological ex- 
amination and SCC. Only cows with quarter 
SCC below 250 x 1 8  cells/ml and negative 
for staphylococci and Gram-negative bacteria 
were transferred to our laboratory, where they 
were housed in individual box stalls in a 
climate-controlled stable. Cows were permitted 
to adjust to the housing facilities and to the 
milking procedures for at least 5 d. Cows were 
given a daily ration of 8 kg of concentrates and 
had free access to hay and water. Feeding was 
at 0730 and 1600 h and did not overlap sam- 
pling or injection. Cows were milked twice a 
day at 0800 and 1900 h using a quarter milker. 
Quarter MP were recorded separately. Mean 
MP was 15.8 f .7 kg/d. 
Inoculation Procedures 
An E. coli strain (P4: serotype 032) recov- 
ered from a cow with a clinical case of bovine 
mastitis was maintained in stock on nutrient 
agar CM3 (Oxoid Ltd., Basingstoke, England) 
at 4'C. For experimental use the organisms 
were subcultured in brain-heart infusion broth 
(CM 225; Oxoid) at 37°C over 3 successive d. 
After washing three times, the culture was 
diluted in pyrogen-free saline immediately 
prior to each experiment. One hour after the 
morning milking, cows were inoculated in 
both quarters of the left udder half with a 
suspension containing 10" cfu of E. colilml. 
Inoculations were made into the teat cistern 
using a sterile teat cannula after aseptic prepa- 
ration of teat ends. Following inoculation each 
gland was massaged for 30 s to distribute the 
solution. 
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Experimental Design 
In a first study, 19 cows suffering from 
experimentally induced E. coli mastitis were 
treated with recombinant bST (40 mg/d) or 
vehicle by daily injection. Each experiment 
comprised a 5-d preinfection period, a 2-d 
mastitis period, a 10-d treatment period, and a 
10-d posttreatment period. Two kinds of 
responders were distinguished based upon the 
respiratory burst activity of blood neutrophils 
and different blood and milk components dur- 
ing the preinfection phase of the experiment 
(29). Nine cows, which had blood neutrophils 
that showed a high capacity to generate reac- 
tive oxygen species, were classified as moder- 
ate responders. The other 10 cows, with a low 
capacity to generate reactive oxygen species, 
were classified as severe responders. Each 
group was randomly subdivided into a placebo 
and a bST group. The four experimental 
groups thus obtained in the first study were 1) 
moderate placebo group (inoculated, receiving 
vehicle, moderate responders; n = 4); 2) moder- 
ate bST group (inoculated, receiving bST, 
moderate responders; n = 5); 3) severe placebo 
group (inoculated, receiving vehicle, severe 
responders; n = 5); and 4) severe bST group 
(inoculated, receiving bST, severe responders; 
n = 5). After the preinfection control period, all 
cows in the four groups received intramam- 
mary (IMM) inoculations of the E. coli suspen- 
sion (d 0). On the inoculation day, placebo 
cows were 34.3 f 5.4 d postpartum; bST cows 
were 27.3 f 1.8 d postpartum. On d +1, all 
cows received systemic (after 24 h) and local 
(after 32 h) antibiotics. A mixture of 
trimethoprim (1 g) and sulfadoxin (5 g) was i.v. 
injected twice a day (Duo rim? Wellcome, 
Aalst, Belgium). Pomesud (500,000 IU of 
polymixin B; Pfzer, Brussels, Belgium) was 
injected into the infected quarters. Antibiotic 
treatment was continued for at least 7 d until 
disappearance of general (e.g., fever) and local 
(e.g., swelling and firmness of mammary 
glands) clinical symptoms. On the morning of 
d +2, cows of the bST group were injected 
subcutaneously (4 ml) with 40 mg of recom- 
binant bST (sometribove; Monsanto Co., St. 
Louis, MO). Cows of the placebo group 
received vehicle only. The bST or vehicle was 
injected in the area around the shoulder after 
thorough disinfection of the skin. Cows were 
treated at 0900 h each day. Treatments were 
maintained for 10 d. The recombinant bST, 
prepared as a dry powder, was solubilized in 
NaHCO3 solution (75 mM) and maintained at 
4°C until used. Stock solutions were made 
every 2nd d. 
In a second study, cows were pretreated 
with long-acting recombinant bST (500 mg, 
bST pretreatment group; n = 5) or vehicle 
(placebo pretreatment group; n = 3) 7 d before 
IMM inoculation of E. coli organisms. Each 
experiment comprised a 5-d pre-bST period, a 
7-d post-bST but preinfection period, and a 
3-wk postinfection period. Pretreatment was by 
subcutaneous injection (1.3 ml) of a single 
dose of either a 14-d prolonged-release system 
of sometribove (Monsanto Co.) or a sterile 
vehicle. 
Milk Sampling Schedule 
Milk was sampled for determination of 
different milk components and for bacteriolog- 
ical examination. During the preinoculation 
control period and during treatment and post- 
treatment periods, for each quarter, daily milk 
samples were taken from evening and from 
morning bulk milk. Evening and morning sam- 
ples were pooled per quarter according to MP 
to give one representative milk sample per day. 
On the day of experimental mastitis, six sam- 
ples (every 3 h) were taken, and, on the day 
thereafter, three samples (every 4 h) were 
taken. For bacteriological examination of milk, 
each sample was immediately streaked on a 
plate of blood agar using an inoculating loop 
designed to deliver .01 ml of milk. Part of each 
sample was kept at 4'C for immediate analysis 
of fresh whole milk. Part was used for skim 
milk preparation by centrifugation at 3000 rpm 
for 20 min. After the fat layer was discarded, 
the skim milk was stored at -20°C until further 
analyses. 
Obsetvations and Analyses 
Milk cells were measured in whole milk 
with a Coulter Counter (ZF; Coulter Electron- 
ics Ltd., Luton, England). Skim milk samples 
were used for analysis of content of casein, 
lactose, serum albumin, and a-lactalbumin ac- 
cording to methods described earlier (29). Milk 
chloride was measured using a chloridemeter 
(EEL 920; Corning, Halstead, England), and 
sodium and potassium were analyzed by flame 
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photometry (IL 243; Instrumentation Labora- 
tory, Milan, Italy). Milk fat (cream) was meas- 
ured using a hematocrit reader (27). 
After induction of mastitis, the cows were 
clinically observed. Cow and quarter observa- 
tions were made at each sample collection as 
well as hourly on d 0 and every 4 h on d + l .  
Rectal temperature, heart rate, respiratory rate, 
attitude, and appetite were evaluated. Quarter 
milk appearance and quarter size, swelling, and 
pain were evaluated. Measurements of body 
weights, MP, and feed intake were made. 
Definitions and Statistical Analyses 
All definitions used in this paper in relation 
to mastitis are in accordance to the definitions 
proposed by the International Dairy Federation 
(14). 
Daily production per quarter was calculated 
for MP, cream, lactose, casein, and N. Means 
per period were taken for infected and unin- 
fected quarters for each cow. Over the entire 
course of the experiments, results were pooled 
into four 5-d periods (period -1, +1, +2, +3) 
and one 2-d period (period 0). The latter in- 
cluded the inoculation day (d 0) and the day 
after inoculation day (d +l). 
Means, standard deviations, standard errors 
of the mean, and Student's t test were com- 
puted according to Snedecor and Cochran (25). 
Differences between groups were calculated 
according to Student's t test. Treatment differ- 
ences within mastitis groups were tested for 
statistical differences by analysis of variance 
with the preinfection period (period -1) as 
covariate. 
RESULTS 
Study 1: Effects of bST Treatment 
of Mastitic Cows 
The IMM E. coli infections in cows shortly 
after calving induced clinical signs of quarter 
inflammation, such as swelling, warmth, and 
firmness of infected glands. These local symp- 
toms were accompanied by systemic distur- 
bances, including fever, tachycardia, mild 
depression, loss of appetite, and general illness 
of the cows. Peak effects were observed be- 
tween 10 and 14 h. Maximal fever, amounting 
to 41.7 f .2'C in the moderate and to 42.0 f 
.2"C in the severe responders, was accompa- 
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nied by tachycardia (92 and 96 beatdmin, 
respectively). For detailed data, see the study 
by Vandeputte-Van Messom et al. (29). In the 
moderate responders, most local and systemic 
symptoms disappeared within 48 h. In the 
severe responders, effects were delayed and 
remained significantly above preinfection lev- 
els for several days. The contralateral unin- 
fected glands did not show any local signs of 
inflammation. From all infected quarters, E. 
coli organisms were isolated within 5 to 6 h 
after inoculation. Multiplication rate in the 
milk was maximally 1.3 x 105 cfdml of milk 
in the moderate responders and 4.5 x 16 c f d  
ml in the severe responders between 18 and 24 
h postinfection. The rate of appearance of SCC 
in the milk was larger in moderate responders 
than in severe responders. Maximal leukocyto- 
sis occurred at 32 (14.7 x lo6) and 48 h 
postinfection (13.7 x lo6), respectively, and 
did not differ significantly between groups. 
The MP of infected and uninfected quarters 
was depressed. Maximal losses in MP 
amounted to 56.2 f 7.1 and 84.7 f 4.3% in the 
infected glands and to 31.6 f 3.3 and 61.2 f 
6.5% in the uninfected glands of moderate and 
severe responders, respectively. Milk K+, fat, 
a-lactalbumin, casein, and lactose decreased; 
Na+, C1-, noncasein N, and serum albumin 
concentrations increased. Changes were most 
pronounced in infected glands and in severe 
responders. In order to evaluate the effects of 
bST treatment on the changes in MP and com- 
position during experimentally induced E. coli 
mastitis, results from infected and uninfected 
glands were discussed separately. In each se- 
ries of results, comparison was made between 
moderate and severe responders and between 
placebo and bST cows within each group. 
For all cows within a group, daily MP 
values from all quarters were averaged to give 
one mean value per quarter and per day. Mean 
daily MP in the infected quarters of the four 
groups is shown in Figure 1. During mastitis 
(period 0). the loss in MP compared with that 
at preinfection is comparable between the 
placebo and the bST cows in both moderate 
and severe responders. In not one of the four 
groups did MP completely return to the prein- 
fection level. Taking into account the initial 
suppression of MP during period 0, compari- 
son of the MP recovery values in both placebo 
and bST cows suggested a slight but nonsig- 
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nificant gain in MP because of bST treatment: 
5% (period +2) in the moderate and 10% 
(period +3) in the severe responders. Concen- 
trations of different milk components before 
and during mastitis and during and after bST 
or vehicle treatment in moderate and severe 
responders are shown in Table 1. During the 
mastitis period, changes in milk components 
were comparable in bST and placebo cows. 
Differences were observed in the course of 
normalization of milk components between the 
different groups. In both moderate placebo and 
bST groups, milk composition gradually 
returned to normal after 32 h postinfection. 
Preinfection levels were obtained after 2 d (for 
K+ and fat), 7 d (for SCC, lactose, and serum 
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Figure 1. Effect of placebo C) or bST treatment p) 
during periods +1 and +2 on milk production in infected 
quarters of peripaaurient moderate (a) and severe (b) 
mponders during experimentally induced fi Escherichia 
coli mastitis. Values are means per quarter and per 24 h 
for a given period. Each period lasted 5 d except period 0, 
which included d 0 and d +1 &r induction of mastitis. 
Vertical bars represent standard errors of the mean. 
albumin), and 12 d (for Na+ and C1-) postinfec- 
tion. In the severe placebo cows, the recovery 
of milk composition was limited and at the end 
of the experiment amounted maximally to 
46.3%. In the severe bST cows, normalization 
started after 72 h postinfection and was max- 
imally 87.6%. The bST effect was most pro- 
nounced during the second half of treatment 
period (period +2) and during the 5 following d 
(period +3), resulting in marked and significant 
differences in milk Na+ (P < .Ol), C1- and 
lactose (P < .001), and a-lactalbumin (P c .02) 
between placebo and bST cows. Treatment 
with bST had no effect upon the rate of nor- 
malization of the number of cells in the milk. 
Yield patterns of different milk components in 
infected quarters paralleled that of MP. In 
moderate responders, recovery of yields of lac- 
tose and fat was 5 and 11% better, respec- 
tively, in bST-treated cows. Recovery of yields 
of a-lactalbumin and casein was 13 and 20% 
better, respectively, in bST cows. In the severe 
responders, losses in yields of lactose, fat, a- 
lactalbumin, and casein during period +3 were 
reduced by 16, 9, 47, and 37%, respectively, 
from those of placebo cows. Although mean 
results showed a recovery for all milk compo- 
nents, their statistical level was, except for that 
of casein (P < .02), nearly significant (P = .07). 
Mean daily MP in the uninfected glands of 
the four groups is shown in Figure 2. Suppres- 
sion of MP during the mastitis period is com- 
parable in the placebo and bST cows of both 
moderate and severe responders. In placebo 
cows, MP recovered maximally by 95 and 
69% in the moderate and severe responders, 
respectively. In the bST cows, however, MP 
increased above preinfection levels by 7 and 
1% in moderate and severe responders, respec- 
tively, a gain in MP in the uninfected glands 
from bST treatment of 12% in moderate and 
32% in severe responders. Recovery of MP in 
the moderate responders (Figure 2a) was 
statistically significant (P = .029). The changes 
in milk composition in the uninfected mam- 
mary glands (Table 2) followed the same pat- 
tern as in the infected quarters. Except for a- 
lactalbumin (P < .Ol), changes during mastitis 
were often negligible in moderate responders. 
During and after bST treatment, concentrations 
of different milk components did not differ 
from those in the placebo cows. In the severe 
responders, significant changes in Na+ (P < 
.Ol), C1- (P < .001), and lactose (P e .01) were 
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observed the day after induction of mastitis. In 
the bST cows, milk composition returned to 
normal within 4 to 5 d after induction of 
mastitis. In the placebo cows, recovery was 
complete only after 12 to 15 d. However, 
during the entire course of the experiment, 
milk Cl- and Na+ remained above, and lactose 
remained below, preinfection level. Only for 
a-lactalbumin (P e .02), Na+ (P < .Ol), and the 
C1- concentration (P e .001) in the milk was a 
significant difference between placebo and 
bST cows observed during periods +2 and +3. 
For both bST-treated moderate and severe 
responders, daily quarter yields of different 
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Figure 2. Effect of placebo e) or bST treatment p) 
during periods +1 and +2 on milk production in the 
uninfected quarters of peripamuient moderate (a) and se- 
vere (b) responders during Escherichia coli mastitis ex- 
perimentally induced 0) in the contralateral glands. 
Values are means per quarter and per 24 h for a given 
period. Each period lasted 5 d except period 0, which 
included d 0 and d +1 after induction of mastitis. Vertical 
bars represent standard errors of the mean. 
milk components returned to or increased 
above preinfection yields during periods +1 
and +2. For the moderate bST cows, this 
change resulted in a gain of 11, 10, 35, and 
31% in the daily quarter yield of lactose, fat, 
a-lactalbumin, and casein, respectively. For 
the severe bST cows, only fat and casein yields 
increased with 2 and 17%, respectively, above 
those preinfection yields. The gain of daily 
yields amounted to 23, 11, 38, and 51%, 
respectively, from bST treatment. Only for 
casein yield was a difference significant (P < 
.05) between both groups. 
Study 2: Effects of bST Pretreatment 
of Mastitic Cows 
Based upon the capacity of blood neu- 
trophils to generate reactive oxygen species 
(with a mean oxygen burst of 1854.6 f 182.9 
mmol of H202/min and number of neutrophils) 
measured before the bST treatment period, 
cows in the second study were classified as 
potentially severe responders. Those cows also 
showed characteristics of severe responders for 
some blood (glucose and packaged cell vol- 
ume) and milk (serum albumin and lactose) 
components prior to infection. For all these 
parameters, data (Table 3) were similar to those 
observed for severe responders in the first 
study and differed significantly (P e .05 to 
.001) from those measured for moderate 
responders [see Vandeputte-Van Messom et al. 
(29) for detailed data]. Pretreatment of peripar- 
turient cows with a single dose of long-acting 
bST stimulated daily MP. Over the entire post- 
bST treatment, preinfection period, the mean 
increase in MP was 16.7 f 2.9 kg per cow (P e 
.005; range, 11 to 27.3 kg). The increase was 
observed for all cows and was most obvious 
between d 3 and 5 after treatment. During the 
same period, MP of placebo-pretreated cows 
was not altered. 
Local inflammation symptoms during E. 
coli mastitis in cows pretreated with bST (n = 
5) were mild and characteristic of a moderate 
form of acute coliform mastitis. Peak fever of 
40.5 f .5"C and tachycardia (96.4 f 4.2 beats/ 
min) were observed around 10 h postinfection. 
In the placebo pretreatment cows, peak effects 
(41.1 & . I T )  were delayed by 2 to 3 h com- 
pared with those of bST pretreatment cows. In 
the infected glands, the number of E. coli 
bacteria rapidly multiplied to a maximum of 
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TABLE 3. Blood and milk components in moderate and severe responders prior to infection.' 
Responders 
Parameter Severe Moderate - - 
X SEM X SEM 
Glucose, gl100 g 49.3 3.2** 59.06 1.98 
Packed cell volume, % 29.1 .9* 31.21 .55 
Burst capacity, nmol H202 x neutrophils 1854.6 182.4*** 3812.4 322.3 
Lactose, gl100 g 4.41 .21* 4.78 14 
Serum albumin, rng/ml .66 .OS** .a4 .04 
SCC, x 1@/ml 138.2 17.3 132.7 11.6 
Fat production, gl24 h 216.6 16.6 174.9 11.3 
Messom et al. (2911: *P c .05, **P < .01, ***P c .001. 
&were responders (n = 8) significantly different from moderate responders [n = 9; for details see Vandeputte-Van 
8.2 X 104 cfdml of milk 12 h postinfection in 
the bST pretreatment cows and to 6.2 f 104 
cfdml of milk in the placebo cows. In the bST 
cows, early bacterial multiplication was rapidly 
followed by leukocytosis into the infected 
glands, which increased maximally to 1.1 x 
lo7 cells/ml between 15 and 27 h after inocu- 
lation. In the placebo cows, maximal leukocy- 
tosis amounting to 1.0 x 107 cells occurred 
between the 27th and the 48th h postinfection. 
The pattern of leukocytosis in the bST 
pretreatment cows was very similar to that in 
moderate responders in the first study (Figure 
3). As expected, based on the pretreatment 
data, the effects in placebo cows resembled 
those observed in severe responders. 
During mastitis, MP was suppressed in both 
infected and uninfected glands of all cows; 
inhibition was maximal on d +1 and d 0, 
respectively. In the uninfected glands of bST 
pretreatment cows, maximal loss in MP 
amounted to 0 and 17.5 f 5.1% (P e .Ol) 
compared with pre- and post-bST treatment 
values, respectively. In the placebo cows, 
losses in MP were maximally 35.3 rt 3.1% 
below preinfection level. In the infected glands 
of bST pretreatment cows, the maximal loss (P 
e .01) in MP amounted to 40.1 It 9.5 and to 
46.1 f 8.9% compared with pre- and post-bST 
MP, respectively. In the placebo cows, MP 
loss was 56.5 f 12.5% greater than preinfec- 
tion values. In all cows, MP returned to normal 
values within 5 to 10 d. Depression of MP in 
the infected glands was, as expected, accompa- 
nied by a significant (P < .001) decrease in 
lactose, milk fat, and K+ and by an increase (P 
e .001) in Na+, C1-, serum albumin, and SCC 
in both groups. In bST cows, the pattern of 
changes in milk composition resembled those 
in moderate responders. In the placebo cows, 
changes resembled those in the severe 
responders. Peak effects were delayed approxi- 
mately 8 h, and complete normalization was 
delayed for several days compared with effects 
in the bST pretreatment cows. 
DISCUSSION 
In periparturient cows suffering from E. coli 
mastitis, recombinant bST seems to have a 
beneficial effect upon the recovery of MP and 
composition. In general, these recovery- 
stimulating effects of bST are more pro- 
nounced in severe responders than in moderate 
responders and more pronounced in the unin- 
fected than in the infected quarters within a 
cow. Because of severe inflammation in in- 
fected quarters of both moderate and severe 
responders, MP did not completely recover. 
The effects of bST upon this recovery were 
very limited; recovery of MP in bST cows was 
maximally only 5% higher than that in the 
placebo cows. In the uninfected contralateral 
quarters, MP completely recovered and even 
increased above preinfection MP in bST- 
treated moderate and in severe responders. Be- 
cause of bST treatment, recovery of MP in 
moderate and severe responders was 12 and 
32% higher, respectively, than in the placebo 
cows. Effects were most obvious during the 
second half of the bST treatment period, which 
is in agreement with observations on healthy 
cows during early lactation (21, 26). On aver- 
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age, although experimental circumstances are 
completely different, the stimulating effects of 
bST on MP are in line with those observed in 
normal lactating cows. It seems that bST can 
influence milk secretion by way of different 
pathways. Several investigators (1, 18, 20) sug- 
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Figure 3. Patterns of leukocyte influx into milk during 
experimentally induced 0 Escherichia coli mastitis 
shortly after calving (a) in cows pretreated with bST (0) or 
the vehicle (0) (data from the second study) and (b) in 
moderate e) and severe p) responders treated with the 
vehicle (data from the first study). Vertical bars represent 
standard errors of the mean. 
gested that, in healthy cows, bST produces its 
effect on MP indirectly by partitioning more 
nutrients to the mammary gland and by en- 
hancing the mammary gland’s ability to syn- 
thesize milk. Recent studies provided evidence 
that alveolar epithelial cells may synthesize 
growth hormone receptors (11). Those findings 
raise the possibility of direct action of growth 
hormone on mammary cells. Both the indirect 
actions on milk production and the direct ac- 
tions on the mammary alveolar epithelium are 
probably partially mediated through insulin- 
like growth factors (9, 12). Also, some of the 
changes may be due to direct action of growth 
hormone-dependent mediators, such as 
somatomedins, on the mammary gland sene- 
tory tissue (20). 
The beneficial effects of bST upon normali- 
zation of milk composition are limited to the 
severe responders. Only for severe responders 
receiving bST did all milk constituents in the 
infected and uninfected glands return to prein- 
fection level. For the severe cows receiving the 
placebo, most milk constituents remained 60 to 
70% below or above preinfection level for the 
entire experiment. In the infected glands of 
moderate responders, recovery was complete 
whether cows received bST or not. Treatment 
with bST had no effect upon recovery of SCC 
in milk. The differences observed in the con- 
centration of several milk components between 
moderate and severe responders during the 
preinfection period were not significant and 
could probably be explained by differences in 
MP and days postpartum between groups. 
Severe responders might be in a stronger nega- 
tive energy balance. Changes in milk composi- 
tion when healthy cows are treated with bST 
usually are minimal and reflect the nutritional 
status of the cow (20). Daily quarter yields of 
most milk components paralleled that of the 
MP. However, unlike the effects in healthy 
cows, mean MP and yield of milk constituents 
did not increase above the initial preinfection 
level. Only in the uninfected glands was this 
level reached or slightly exceeded. 
Normalization of milk composition in 
mastitic cows suggests restoration of the in- 
tegrity of the blood-milk barrier. From the 
present study, bST apparently helps to restore 
the integrity of the blood-milk barrier damaged 
during IMM infection only in the severe 
responders. The different effects of bST on 
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normalization of MP and composition in 
mastitic moderate and severe responders can 
be connected to differences in the role of en- 
dotoxins and leukocytes in both groups. Ef- 
fects induced by E. coli mastitis in severe 
responders resembled those induced by in- 
travenous challenge with endotoxin (6). The 
delayed leukocyte influx in this group seems to 
be responsible for the massive release of en- 
dotoxin, which seriously affects the integrity of 
the blood-milk barrier. After absorption into 
circulation, endotoxin has a serious impact 
upon the blood profile of the cows and proba- 
bly affects the synthesis of different milk con- 
stituents. These cows have difficulties in 
restoring their milk secretion spontaneously, 
and, consequently, the integrity of the blood- 
milk barrier remains weak. The effects are 
therefore severe and of long duration. In these 
cows, leukocytes may play an important role in 
detoxification of endotoxins in the damaged 
glands. Endotoxins are known to be detoxified 
by the lysosomal enzyme acyloxyacyl hy- 
droxylase in blood and milk neutrophils (17). 
After bST administration in normal healthy 
subjects, lysosomal enzyme activities of poly- 
morphonuclear leukocytes increased, suggest- 
ing that this substance may influence the func- 
tional activity of polymorphonuclear leuko- 
cytes (23). In the cow, bST seems to influence 
the maturation and function of the neutrophils 
[(16); C. Burvenich et al., 1993, unpublished 
data]. Thus, in severe responders, stimulation 
of leukocyte function by bST may contribute 
to the cow’s defense system. In moderate 
responders, effects resembled those during E. 
coli endotoxin (lipopolysaccharide) mastitis in 
ruminants (7). In such experimental circum- 
stances, absorption of endotoxin into circula- 
tion is, although not entirely excluded, very 
unlikely. The effects observed may rather be 
ascribed to formation of endopyrogens in in- 
flamed glands and their subsequent release into 
circulation (32). In the moderate responders, 
most of the endotoxins are probably detoxified 
in the mammary gland as a result of the fast 
influx of blood neutrophils into the milk. In 
those cows, the effects of coliform mastitis are 
therefore of short duration without serious im- 
pact upon milk secretion. Consequently, the 
spontaneous restoration of the milk secretion 
process promotes the integrity of the blood- 
milk barrier. Under these circumstances, 
stimulation of leukocyte function by bST treat- 
ment is apparently not of any advantage to the 
cow’s defense system. 
The results from the first study, suggesting 
that the role of leukocytes in the outcome and 
development of mastitis and the effect of bST 
on leukocyte function are more important in 
severe than in moderate responders and that 
bST interferes with the leukocyte detoxifica- 
tion of endotoxin in the mammary gland, are 
supported by observations in the second study. 
In addition to a stimulating effect on MP in 
healthy quarters, pretreatment with bST seems 
to protect the mammary gland from excessive 
loss in MP during the subsequently induced 
coliform mastitis. These observations are in 
line with those observed in the goat during 
endotoxin mastitis (4). The present study 
shows that pretreatment of cows with bST 
could not prevent the suppression of MP dur- 
ing the subsequently induced E. coli mastitis. 
However, losses in MP and compositional 
changes of milk were limited, and bST acceler- 
ated the recovery of mastitic cows. Thus, it 
seems that newly calved cows, which show all 
characteristics of severe responders, after 
pretreatment with bST will react as moderate 
responders to IMM E. coli infection. Earlier C. 
Burvenich et al. (1993, unpublished data); and 
Massart-Wn et al. (16) observed that pretreat- 
ment of cows with bST shortly after calving 
increased the number of circulating immature 
band cells. These observations and the present 
data indicate that the beneficial effects of bST 
on the recovery of newly calved cows during 
E. coli mastitis could probably be ascribed to 
enhancement of the rate of diapedesis of the 
neutrophils into the milk during early infec- 
tion; to mobilization of mature and immature 
neutrophils from bone marrow into the cir- 
culating pool, thereby increasing the neutrophil 
number; and to stimulation of their reactive 
oxygen species producing activity. 
Clinical mastitis in dairy cows is usually 
treated by IMM antibiotics, which function by 
destroying life-maintaining processes of bac- 
terial cells. However, the role that antibiotics 
play in the therapy of coliform mastitis is 
doubtful. Many coliform mastitis cases are 
self-limiting and cure without antibiotic treat- 
ment; in contrast, some cows die despite an 
early and intense antibiotic treatment. In the 
present experiments, cows received a local and 
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systemic antibiotic treatment. No other drugs 
were administered. The observed effects must 
therefore be considered to be the result of the 
combination of bST and antibiotics. The sub- 
stantial contribution of antibiotic therapy to the 
faster and better recovery observed in bST- 
treated cows during experimentally induced E. 
coli mastitis is not clear from the present ex- 
periments because polymixin drastically 
reduced the number of growing bacteria in 
infected glands of placebo as well as of bST- 
treated cows. However, recovery of milk quan- 
tity and quality was only markedly improved 
in bST-treated cows. 
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